Literature DB >> 20386106

The effect of HAART on HIV RNA trajectory among treatment-naïve men and women: a segmental Bernoulli/lognormal random effects model with left censoring.

Haitao Chu1, Stephen J Gange, Xiuhong Li, Donald R Hoover, Chenglong Liu, Joan S Chmiel, Lisa P Jacobson.   

Abstract

BACKGROUND: Highly active antiretroviral therapy (HAART) rapidly suppresses human immunodeficiency virus (HIV) viral replication and reduces circulating viral load, but the long-term effects of HAART on viral load remain unclear.
METHODS: We evaluated HIV viral load trajectories over 8 years following HAART initiation in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. The study included 157 HIV-infected men and 199 HIV-infected women who were antiretroviral naive and contributed 1311 and 1837 semiannual person-visits post-HAART, respectively. To account for within-subject correlation and the high proportion of left-censored viral loads, we used a segmental Bernoulli/lognormal random effects model.
RESULTS: Approximately 3 months (0.30 years for men and 0.22 years for women) after HAART initiation, HIV viral loads were optimally suppressed (ie, with very low HIV RNA) for 44% (95% confidence interval = 39%-49%) of men and 43% (38%-47%) of women, whereas the other 56% of men and 57% of women had on average 2.1 (1.5-2.6) and 3.0 (2.7-3.2) log10 copies/mL, respectively.
CONCLUSION: After 8 years on HAART, 75% of men and 80% of women had optimal suppression, whereas the rest of the men and women had suboptimal suppression with a median HIV RNA of 3.1 and 3.7 log10 copies/mL, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386106      PMCID: PMC3736572          DOI: 10.1097/EDE.0b013e3181ce9950

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  30 in total

1.  Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy.

Authors:  P M Tarwater; J B Margolick; J Jin; J P Phair; R Detels; C Rinaldo; J Giorgi; A Muñoz
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

2.  Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.

Authors:  T E Yamashita; J P Phair; A Muñoz; J B Margolick; R Detels; S J O'Brien; J W Mellors; S M Wolinsky; L P Jacobson
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

3.  Mixed effects models with censored data with application to HIV RNA levels.

Authors:  J P Hughes
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

4.  Mixture models for quantitative HIV RNA data.

Authors:  Lawrence H Moulton; Frank C Curriero; Paulo F Barroso
Journal:  Stat Methods Med Res       Date:  2002-08       Impact factor: 3.021

5.  Repeated measures with zeros.

Authors:  K N Berk; P A Lachenbruch
Journal:  Stat Methods Med Res       Date:  2002-08       Impact factor: 3.021

6.  A mixture model with detection limits for regression analyses of antibody response to vaccine.

Authors:  L H Moulton; N A Halsey
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

7.  Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.

Authors:  G Dornadula; H Zhang; B VanUitert; J Stern; L Livornese; M J Ingerman; J Witek; R J Kedanis; J Natkin; J DeSimone; R J Pomerantz
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

8.  Correlating two viral load assays with known detection limits.

Authors:  R H Lyles; J K Williams; R Chuachoowong
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

9.  Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.

Authors:  Frank J Palella; Maria Deloria-Knoll; Joan S Chmiel; Anne C Moorman; Kathleen C Wood; Alan E Greenberg; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2003-04-15       Impact factor: 25.391

10.  Viral blip dynamics during highly active antiretroviral therapy.

Authors:  Michele Di Mascio; Martin Markowitz; Michael Louie; Christine Hogan; Arlene Hurley; Chris Chung; David D Ho; Alan S Perelson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more
  16 in total

1.  Opening the black box of biomarker measurement error.

Authors:  Enrique F Schisterman; Roderick J Little
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

2.  Estimating the odds ratio when exposure has a limit of detection.

Authors:  Stephen R Cole; Haitao Chu; Lei Nie; Enrique F Schisterman
Journal:  Int J Epidemiol       Date:  2009-08-10       Impact factor: 7.196

3.  Bayesian inference for skew-normal mixture models with left-censoring.

Authors:  Getachew A Dagne
Journal:  J Biopharm Stat       Date:  2013       Impact factor: 1.051

4.  Estimation and inference on correlations between biomarkers with repeated measures and left-censoring due to minimum detection levels.

Authors:  Xianhong Xie; Xiaonan Xue; Stephen J Gange; Howard D Strickler; Mimi Y Kim
Journal:  Stat Med       Date:  2012-06-19       Impact factor: 2.373

5.  Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.

Authors:  Maria C Villacres; Naoko Kono; Wendy J Mack; Marek J Nowicki; Kathryn Anastos; Michael Augenbraun; Chenglong Liu; Alan Landay; Ruth M Greenblatt; Stephen J Gange; Alexandra M Levine
Journal:  J Infect Dis       Date:  2012-06-12       Impact factor: 5.226

6.  Community viral load as a measure for assessment of HIV treatment as prevention.

Authors:  William C Miller; Kimberly A Powers; M Kumi Smith; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2013-03-25       Impact factor: 25.071

7.  Analysis of cigarette purchase task instrument data with a left-censored mixed effects model.

Authors:  Wenjie Liao; Xianghua Luo; Chap T Le; Haitao Chu; Leonard H Epstein; Jihnhee Yu; Jasjit S Ahluwalia; Janet L Thomas
Journal:  Exp Clin Psychopharmacol       Date:  2013-01-28       Impact factor: 3.157

8.  The Use of Multiple Imputation for Data Subject to Limits of Detection.

Authors:  Ofer Harel; Neil Perkins; Enrique F Schisterman
Journal:  Sri Lankan J Appl Stat       Date:  2014-12-15

9.  Effectiveness of combination packages for HIV-1 prevention in sub-Saharan Africa depends on partnership network structure: a mathematical modelling study.

Authors:  Samuel M Jenness; Steven M Goodreau; Martina Morris; Susan Cassels
Journal:  Sex Transm Infect       Date:  2016-06-09       Impact factor: 3.519

10.  Estimation of HIV incidence using multiple biomarkers.

Authors:  Ron Brookmeyer; Jacob Konikoff; Oliver Laeyendecker; Susan H Eshleman
Journal:  Am J Epidemiol       Date:  2013-01-09       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.